SELLAS Life Sciences Group, Inc. has entered into a Securities Purchase Agreement to sell 8.2 million shares and 11.5 million pre-funded warrants, raising approximately $25 million from a healthcare-focused institutional investor at a price of $1.27 per share. The offering is expected to close on January 29, 2025, with certain restrictions on future stock issuance for 105 days.